A Phase III, Randomized, Open, Parallel-controlled, Multi-center Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Tacrolimus (Primary) ; Cyclophosphamide; Prednisone
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 11 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Sep 2018.
- 11 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.
- 09 Apr 2018 Status changed from recruiting to active, no longer recruiting.